Zenas BioPharma Appoints Lisa von Moltke, M.D., as Head of Research and Development and Chief Medical Officer
Portfolio Pulse from
Zenas BioPharma has appointed Dr. Lisa von Moltke as Head of Research and Development and Chief Medical Officer. Dr. von Moltke brings over 30 years of experience in drug development and clinical and regulatory success.
March 17, 2025 | 11:15 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Zenas BioPharma has appointed Dr. Lisa von Moltke as Head of Research and Development and Chief Medical Officer, enhancing its leadership with her extensive experience in drug development.
The appointment of Dr. von Moltke, with her extensive experience, is likely to positively impact Zenas BioPharma by enhancing its research and development capabilities, potentially leading to successful drug development and regulatory approvals.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80